Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Ways To Improve Monthly Budgeting With Analysis guides you to translate insights into concrete budget tweaks that save money.
21,748 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
When geopolitics and supply chains collide, a single stock can surge. This article breaks down why rare earth stock s...
Rigetti Computing lives at the edge of technology and finance. This article breaks down the revenue puzzle, the risks...
A notable AI stock has fallen about 30% this year. This article lays out a practical, battle-tested framework to judg...
A major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
EchoStar joined the S&P 500 on March 23, 2026, carrying unusually high short interest. This article examines the setu...
The Tomi (Tomz) 2026 earnings season offers clues about growth, margins, and strategy. This guide breaks down what to...
A surprise move in crypto rankings highlights the push and pull around privacy coins. This guide breaks down what zca...
As economists debate the timing of a downturn, real-time indicators suggest that the market moves first and the headl...
When a stock suddenly pops, traders buzz and headlines flare. This guide breaks down why those moves happen, how to t...
Insider activity can be a clue about a company’s path, but the motives are varied. This article dissects iradimed's s...
A 56-year-old hospital administrator faces a potential half-million-dollar federal tax bill on an inherited $1.8 mill...